SlideShare a Scribd company logo
1 of 3
Liver Function Testing (LFT) in Primary Care:
Retrospective Case Note Review of 100 Patients
with Abnormal LFTs in 2 Tayside General Practices
University of Dundee
Medical Research Institute
Dr Chris Weatherburn, Academic Clinical Fellow
Prof Bruce Guthrie, Professor of Primary Care Medicine, University of Dundee
University of Dundee
Medical Research Institute
Objectives
In order to inform design of new laboratory reporting and care pathway, to examine:
• Indications for LFT testing in primary care in Tayside
• Prevalence and management of abnormal results
• Feasibility of implementing validated algorithms for calculating risk of death within 1 year
and chance of a liver disease diagnosis in the next 24 months(1) (2)
Abdominal Pain, Tired all the time, Unwell 28
Abnormal LFTs being repeated, Alcohol abuse 6
Diabetes review, Health check, Other monitoring 60
Secondary care request, no reason documented 6
Reason LFT Taken
References
1. McLernon DJ, Dillon JF, Sullivan FM, Roderick P, Rosenberg WM, Ryder SD, Donnan PT. The Utility of Liver FunctionTests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI). PLoS One:2012;7(12):e50965.
2. McLernon DJ, Donnan PT, Sullivan FM, Roderick P, Rosenberg WM, Ryder SD, Dillon JF. Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts. BMJ Open 2014;4:e004837.
University of Dundee
Medical Research Institute
Results
Conclusion
• 7 patients had Hepatitis B and C tested 7
patients had Immunology checked
• 13 patients appeared to have new LFT
abnormalities
• Majority of LFTs checked are for planned
monitoring
• Feasible to implement risk prediction tools
based on information in GP record but utility
unclear
• 17 documented suspected diagnosis
accounting for LFT abnormalities:
• 6 Alcohol induced fatty liver
• 4 Gilbert’s syndrome
• 3 Fatty liver (non alcohol related)
• 2 Drug Reactions *
• 1 Gallstones
• 1 Malignancy *
0
1
2
3
4
5
16 17 19 23 25 28 33 35 44 49 50 51 52 54 55 56 57 58 59 61 62 63 64 65 66 67 68 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 94 102
%
Predicted % Chance of Liver Diagnosis within 2 Years based on LFTs Values against Age

More Related Content

What's hot

Presentation ท่าหลวง260656
Presentation ท่าหลวง260656Presentation ท่าหลวง260656
Presentation ท่าหลวง260656
Komen Chawarit
 
Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013
iberzamz
 
AC Chemo CRC ASCO Poster
AC Chemo CRC ASCO PosterAC Chemo CRC ASCO Poster
AC Chemo CRC ASCO Poster
Maha Hassan
 
CompAct - Adherence Series 2014
CompAct - Adherence Series 2014CompAct - Adherence Series 2014
CompAct - Adherence Series 2014
pa21vifor
 
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
dylanturner22
 

What's hot (20)

Ca prostata
Ca prostataCa prostata
Ca prostata
 
14 ijcse-01234
14 ijcse-0123414 ijcse-01234
14 ijcse-01234
 
Biopsychosocial Factors of Gastric Banding Patients in a Greek Population
Biopsychosocial Factors of Gastric Banding Patients in a Greek Population  Biopsychosocial Factors of Gastric Banding Patients in a Greek Population
Biopsychosocial Factors of Gastric Banding Patients in a Greek Population
 
Open Journal of Surgery
Open Journal of SurgeryOpen Journal of Surgery
Open Journal of Surgery
 
Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on ...
Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on ...Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on ...
Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on ...
 
Wolfe (2011) fibromyalgia criteria and severity scales for clinical and epide...
Wolfe (2011) fibromyalgia criteria and severity scales for clinical and epide...Wolfe (2011) fibromyalgia criteria and severity scales for clinical and epide...
Wolfe (2011) fibromyalgia criteria and severity scales for clinical and epide...
 
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
 
Presentation ท่าหลวง260656
Presentation ท่าหลวง260656Presentation ท่าหลวง260656
Presentation ท่าหลวง260656
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
GI CANCER SCREENING
GI CANCER SCREENINGGI CANCER SCREENING
GI CANCER SCREENING
 
Niraj_Pandey_Summary_InvDiab
Niraj_Pandey_Summary_InvDiabNiraj_Pandey_Summary_InvDiab
Niraj_Pandey_Summary_InvDiab
 
Wesat2003
Wesat2003Wesat2003
Wesat2003
 
Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013
 
AC Chemo CRC ASCO Poster
AC Chemo CRC ASCO PosterAC Chemo CRC ASCO Poster
AC Chemo CRC ASCO Poster
 
The role of primary care in the management of crf patients
The role of primary care in the management of crf patientsThe role of primary care in the management of crf patients
The role of primary care in the management of crf patients
 
CompAct - Adherence Series 2014
CompAct - Adherence Series 2014CompAct - Adherence Series 2014
CompAct - Adherence Series 2014
 
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
 
Covid 19 and git
Covid 19 and gitCovid 19 and git
Covid 19 and git
 
Hepatitis c guidance 2018 update aasld idsa recommendations for testing, mana...
Hepatitis c guidance 2018 update aasld idsa recommendations for testing, mana...Hepatitis c guidance 2018 update aasld idsa recommendations for testing, mana...
Hepatitis c guidance 2018 update aasld idsa recommendations for testing, mana...
 

Similar to SAPC2015 ChrisWeatherburn final slide 080715

ELAD study vti 208 - Maimonides Team Brooklyn Dinner - March 4 2014
ELAD study vti 208  - Maimonides Team Brooklyn Dinner - March 4 2014ELAD study vti 208  - Maimonides Team Brooklyn Dinner - March 4 2014
ELAD study vti 208 - Maimonides Team Brooklyn Dinner - March 4 2014
Dr. Lewis Teperman
 
tx outcomes POne.0061568(1)
tx outcomes POne.0061568(1)tx outcomes POne.0061568(1)
tx outcomes POne.0061568(1)
Myrna Cozen
 
Poster Jinender
Poster JinenderPoster Jinender
Poster Jinender
jinender16
 
1-s2.0-S0272638616305741-main
1-s2.0-S0272638616305741-main1-s2.0-S0272638616305741-main
1-s2.0-S0272638616305741-main
Marie-Louise Loos
 
The importance of sex and gender in medical research
The importance of sex and gender in medical researchThe importance of sex and gender in medical research
The importance of sex and gender in medical research
Coda Change
 
Natalie Duran - Publications-Abstracts
Natalie Duran - Publications-AbstractsNatalie Duran - Publications-Abstracts
Natalie Duran - Publications-Abstracts
Natalie Duran
 

Similar to SAPC2015 ChrisWeatherburn final slide 080715 (20)

NASH Patient POV with Zobair Younossi, MD
NASH Patient POV with Zobair Younossi, MDNASH Patient POV with Zobair Younossi, MD
NASH Patient POV with Zobair Younossi, MD
 
ECO 11: Medicines Optimisation Through Precision - Sir Munir Pirmohamed
ECO 11: Medicines Optimisation Through Precision - Sir Munir PirmohamedECO 11: Medicines Optimisation Through Precision - Sir Munir Pirmohamed
ECO 11: Medicines Optimisation Through Precision - Sir Munir Pirmohamed
 
Eama presentation nicolas martinez velilla avila 2015 final
Eama presentation nicolas martinez velilla avila 2015 finalEama presentation nicolas martinez velilla avila 2015 final
Eama presentation nicolas martinez velilla avila 2015 final
 
Role of Biomarkers in Alzheimers Disease
Role of Biomarkers in Alzheimers DiseaseRole of Biomarkers in Alzheimers Disease
Role of Biomarkers in Alzheimers Disease
 
Journal presentation
Journal presentationJournal presentation
Journal presentation
 
Update on NAFLD NASH.pptx
Update on NAFLD NASH.pptxUpdate on NAFLD NASH.pptx
Update on NAFLD NASH.pptx
 
ELAD study vti 208 - Maimonides Team Brooklyn Dinner - March 4 2014
ELAD study vti 208  - Maimonides Team Brooklyn Dinner - March 4 2014ELAD study vti 208  - Maimonides Team Brooklyn Dinner - March 4 2014
ELAD study vti 208 - Maimonides Team Brooklyn Dinner - March 4 2014
 
Dyspepsia - An Evidence Based Approach
Dyspepsia - An Evidence Based ApproachDyspepsia - An Evidence Based Approach
Dyspepsia - An Evidence Based Approach
 
tx outcomes POne.0061568(1)
tx outcomes POne.0061568(1)tx outcomes POne.0061568(1)
tx outcomes POne.0061568(1)
 
Poster Jinender
Poster JinenderPoster Jinender
Poster Jinender
 
1-s2.0-S0272638616305741-main
1-s2.0-S0272638616305741-main1-s2.0-S0272638616305741-main
1-s2.0-S0272638616305741-main
 
Chronic kidney disease: a quiet revolution in nephrology
Chronic kidney disease: a quiet revolution in nephrology Chronic kidney disease: a quiet revolution in nephrology
Chronic kidney disease: a quiet revolution in nephrology
 
Louvet et al-2007-hepatology
Louvet et al-2007-hepatologyLouvet et al-2007-hepatology
Louvet et al-2007-hepatology
 
Depression and cognitive impairment in peritoneal dialysis a multicenter cros...
Depression and cognitive impairment in peritoneal dialysis a multicenter cros...Depression and cognitive impairment in peritoneal dialysis a multicenter cros...
Depression and cognitive impairment in peritoneal dialysis a multicenter cros...
 
journal club ppt..pptx
journal club ppt..pptxjournal club ppt..pptx
journal club ppt..pptx
 
The importance of sex and gender in medical research
The importance of sex and gender in medical researchThe importance of sex and gender in medical research
The importance of sex and gender in medical research
 
CKD brief overview.pptx
CKD brief overview.pptxCKD brief overview.pptx
CKD brief overview.pptx
 
27.SAR 2014
27.SAR 201427.SAR 2014
27.SAR 2014
 
Natalie Duran - Publications-Abstracts
Natalie Duran - Publications-AbstractsNatalie Duran - Publications-Abstracts
Natalie Duran - Publications-Abstracts
 
Journal club : Gallstone pancreatitis
Journal club : Gallstone pancreatitisJournal club : Gallstone pancreatitis
Journal club : Gallstone pancreatitis
 

SAPC2015 ChrisWeatherburn final slide 080715

  • 1. Liver Function Testing (LFT) in Primary Care: Retrospective Case Note Review of 100 Patients with Abnormal LFTs in 2 Tayside General Practices University of Dundee Medical Research Institute Dr Chris Weatherburn, Academic Clinical Fellow Prof Bruce Guthrie, Professor of Primary Care Medicine, University of Dundee
  • 2. University of Dundee Medical Research Institute Objectives In order to inform design of new laboratory reporting and care pathway, to examine: • Indications for LFT testing in primary care in Tayside • Prevalence and management of abnormal results • Feasibility of implementing validated algorithms for calculating risk of death within 1 year and chance of a liver disease diagnosis in the next 24 months(1) (2) Abdominal Pain, Tired all the time, Unwell 28 Abnormal LFTs being repeated, Alcohol abuse 6 Diabetes review, Health check, Other monitoring 60 Secondary care request, no reason documented 6 Reason LFT Taken References 1. McLernon DJ, Dillon JF, Sullivan FM, Roderick P, Rosenberg WM, Ryder SD, Donnan PT. The Utility of Liver FunctionTests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI). PLoS One:2012;7(12):e50965. 2. McLernon DJ, Donnan PT, Sullivan FM, Roderick P, Rosenberg WM, Ryder SD, Dillon JF. Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts. BMJ Open 2014;4:e004837.
  • 3. University of Dundee Medical Research Institute Results Conclusion • 7 patients had Hepatitis B and C tested 7 patients had Immunology checked • 13 patients appeared to have new LFT abnormalities • Majority of LFTs checked are for planned monitoring • Feasible to implement risk prediction tools based on information in GP record but utility unclear • 17 documented suspected diagnosis accounting for LFT abnormalities: • 6 Alcohol induced fatty liver • 4 Gilbert’s syndrome • 3 Fatty liver (non alcohol related) • 2 Drug Reactions * • 1 Gallstones • 1 Malignancy * 0 1 2 3 4 5 16 17 19 23 25 28 33 35 44 49 50 51 52 54 55 56 57 58 59 61 62 63 64 65 66 67 68 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 94 102 % Predicted % Chance of Liver Diagnosis within 2 Years based on LFTs Values against Age